期刊文献+

高灵敏纳米金比色芯片检测乙型肝炎病毒DNA及其变异 被引量:13

A Visual DNA Microarray for High Sensitivity Detection of Hepatitis B Virus DNA and Single Nucleotide Polymorphisms
下载PDF
导出
摘要 构建了新型纳米金比色芯片,利用Taq DNA连接酶的连接特异性,将其与乙型肝炎病毒DNA(HBV-DNA)靶序列完全互补杂交的捕获探针(固定在芯片上)和纳米金修饰的探针连接成一条链,从而将纳米金颗粒固定到芯片点阵上,再通过银染反应放大,形成裸眼可见的显色信息。通过点阵的位置及灰度,即可判断HBV-DNA靶序列的单碱基突变,并得出相对定量信息。本实验对不同浓度的HBV-DNA靶序列进行了检测。结果显示:此技术对单碱基突变有很强的特异性识别能力,并且具有较高的灵敏度(约10pmol/L),在10~100pmol/L浓度范围内表现出较好的线性关系。该技术检测时间短(<1h)、操作简单、不需要特殊的检测设备,具有很好的临床应用前景。 Hepatitis B is a major disease which causes serious public health problems worldwide.Herein,a visual DNA microarray was developed for sensitive and specific detection of hepatitis B virus DNA(HBV-DNA) and single nucleotide polymorphisms.5′ end amino-modified oligonucleotide,which was immobilized on microarray surface acted as capture probe,and another part of gold nanoparticle-labeled oligonucleotide were designed to bind specifically to complementary targets HBV-DNAt,and then linked as a single-strand DNA via Taq DNA ligase.The black image of microarray spots,resulting from silver stain on gold nanoparticles,was used to detect visually target HBV-DNA and single nucleotide polymorphisms.Capture probe with single base mismatch was prepared to detect specificity and sensitivity of hybridization on microarray.Target HBV-DNA with different concentration had been tested,the result indicated that this method had good specificity in the discrimination of single nucleotide polymorphisms and showed high sensitivity(about 10 pmol/L).There is also a linear relationship between the signal intensity of microarray spots and the concentration of target DNA at the concentration range of 10-100 pmol/L.For its high sensitivity and good specificity,this visual detecting technique has potential applications in clinical fields.
出处 《分析化学》 SCIE CAS CSCD 北大核心 2012年第4期569-573,共5页 Chinese Journal of Analytical Chemistry
基金 上海市科委纳米专项(Nos.11nm0505800 1052nm061000) 国家自然科学基金(No.31000791)资助项目
关键词 乙型肝炎病毒 纳米金 基因芯片 TaqDNA连接酶 Hepatitis B virus Gold-nanoparticles Deoxyribonucleic acid chip Taq deoxyribonucleic acid Ligase
  • 相关文献

参考文献4

二级参考文献45

  • 1TANG Ren Xian, GAO Feng Guang, ZENG Ling Yu, WANG Ying Wei and WANG Yu Long.Detection of HBV DNA and its existence status in liver tissues and peripheral blood lymphocytes from chronic hepatitis B patients[J].World Journal of Gastroenterology,1999,5(4):87-89. 被引量:27
  • 2孙正伟,张源潮.HBV基因型与拉米夫定疗效相关性的研究[J].国外医学(病毒学分册),2002,9(3):96-96. 被引量:5
  • 3Zoulim F. Mechanismof viral persistence and resistance to nueleoside and nucleotide analogs in chronic hepatitis B virus infection. Antiviral Res, 2004, 64:1-15.
  • 4Chen JY, Wang LW, Sun XM, et al. Effects of HBV gene variati ons on disease development and antivira| therapy for patients with chronic hepatitis B. Hepat obiliary PancreatDis lnt, 2005, 4: 393- 397.
  • 5Marc G, Liang TJ. Drug Targets and Molecular Mechanisms of Drug Resistance in Chronic Hepatitis B. Gastroenterology, 2007, 132 : 1574-1585.
  • 6Barthotomeusz A, Loearnini SA, Ayres A, et al. Mechanistic basis for hepatitis B virus resistance to acyclie nueleoside phosphonate analogues, Adefovir and Tenofovir. Hepatology, 2005,42, 594A.
  • 7Westland CE, Yang H, Delaney WE, et al. Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients. J Viral Hepat, 2005,12: 67-73.
  • 8Borroto-Esoda K, Miller MD, Arterburn S. Metaanalysis across adefovir clinical trials demonstrates the absence of novel adefovir-associated mutations and eonfirms the role of the rtA181V and rtA236T mutations in HBV polymerase with virologic failure. Hepatology, 2006,44 : 552A.
  • 9Schildgen O, Sirma H. Variant of Hepatitis B Virus with Primary Resistance to Adefovir. N Engl J Med, 2006,354:17.
  • 10Bartholomeusz A, Locarnini SA. Antiviral drug resistance: clinical consequences and molecular aspects. Semin Liver Dis, 2006,26: 162-170.

共引文献37

同被引文献116

引证文献13

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部